Mount Sinai extends home care offering

Mount Sinai Health System has extended its partnership with home-based care provider Contessa to offer a full continuum of home-based services as Mount Sinai at Home.

The move brings Mount Sinai South Nassau’s home health agency into the existing joint venture between Contessa and Mount Sinai, and the care offerings will include home health, hospitalization at home, rehabilitation at home (in lieu of care at a skilled nursing facility) and palliative care at home. 

The move comes as the home-based care sector is expected to grow over the coming years as Baby Boomers continue to age, with many wishing to age in place at home. Employment in the home healthcare sector is expected to grow 33% from 2020 to 2030, adding nearly 600,000 jobs, according to the Bureau of Labor Statistics. The move also comes as the COVID-19 pandemic has incentivized Americans to receive care at home when possible to avoid the risk of exposure to the virus. Additionally, the declines of referrals to skilled nursing facilities influenced Mount Sinai’s decision to expand its home-based care offerings, the company said in a press release. 

“The pandemic forced healthcare into the home, and it is a trend that is only growing,” Margaret Pastuszko, President and Chief Operating Officer of the Mount Sinai Health System, said in a statement. “Mount Sinai at Home builds upon this momentum and offers consolidated opportunities for patients and physicians, decreasing the fragmentation that often plagues the healthcare industry. It’s exciting to be creating a care model that is blazing the trail for advanced care at home.”

Contessa, which is owned by home care giant Amedisys, began its partnership with Mount Sinai in 2017 to provide hospitalization at home before expanding in 2021 to offer palliative care at home. Mount Sinai at Home reaches 3,000 patients annually.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.